Bioauxilium is a private Canadian biotechnology company founded by seasoned scientists from PerkinElmer (now Revvity). We are on a mission to disrupt the drug discovery reagents market by providing premium quality yet highly affordable TR-FRET assay kits and reagents to the biomedical sciences community. 
Bioauxilium’s kits are based on its proprietary THUNDER® TR-FRET technology. They are offered at an outstanding value and are supported by expert technical support.
Bioauxilium also provides on a contract basis customized services in assay development using diverse cutting-edge technologies.

Our services:
🔹 Custom TR-FRET-based assay development
🔹 Custom assay kit development and manufacturing
🔹 Conversion of ELISAs into homogeneous TR-FRET immunoassays amenable to automation using your antibody pair or our “best pair” screening service
🔹 Custom labeling: labeling of biomolecules with lanthanides, fluorophores or biotin to build reagent tools necessary for TR-FRET assay development
🔹 Custom biochemical, cell-based and biomarker assay development using multiple technology platforms (TR-FRET, luminescence, AlphaScreen, AlphaLISA)
🔹 Assay design, development, optimization and validation for drug discovery research, from HTS to lead optimization

Bioauxilium

Org chart

Teams

Offices